Identifying Proteins Linked to Prostate Cancer Progression
Author Information
Author(s): Riddick A C P, Shukla C J, Pennington C J, Bass R, Nuttall R K, Hogan A, Sethia K K, Ellis V, Collins A T, Maitland N J, Ball R Y, Edwards D R
Primary Institution: Norfolk and Norwich University Hospital NHS Trust
Hypothesis
Can the expression of degradome components in human prostatic tissues be linked to prostate cancer progression?
Conclusion
The study identifies several genes involved in proteolysis as potential prognostic indicators for prostate cancer.
Supporting Evidence
- Increased expression of MMP10, 15, 24, 25, and 26 was found in malignant tissue.
- Expression of MMP15 and MMP26 correlated positively with Gleason score.
- Decreased expression of MMP2 and MMP23 was observed in cancer specimens.
Takeaway
Researchers looked at tissue samples from men with prostate cancer and found certain proteins that could help predict how the cancer might progress.
Methodology
Quantitative real-time RT–PCR analysis was used to measure mRNA levels in malignant and benign prostate tissues.
Potential Biases
Potential bias in sample selection and the interpretation of gene expression data.
Limitations
The study primarily focused on mRNA levels without confirming protein expression.
Participant Demographics
44 patients with malignant prostate cancer and 23 patients with benign prostatic hyperplasia.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website